Organ Transplantability Evaluation via Perfusion Marker Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional organ transplantation methods lack objective criteria for determining the transplantability of organs, leading to potential primary non-function (PNF) issues, especially with vital organs like the heart, lung, and liver, resulting in graft loss and patient risk.

Innovation Solution

A method involving perfusion of organs with a perfusate to evaluate function by measuring changes in marker substances over time using mass spectrometry, providing an objective indicator for transplantability through a set evaluation criterion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional transplantation methods relying on surgeon experience and prompt histopathological diagnosis are used, then the decision-making process is simple and quick, but the accuracy of determining organ transplantability is insufficient leading to primary non-function

Engineering Contradiction:
Improveaccuracy of organ transplantability determinationVSAvoidcomplexity of evaluation system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention performs preliminary evaluation of organ function before transplantation by measuring marker substance contents and calculating indicators. This advance assessment allows determination of organ transplantability prior to the actual transplantation procedure, preventing primary non-function while maintaining a manageable evaluation process through standardized measurements and calculations.

Inventive Principle:
Principle #10Preliminary action

2Quantity of substance

If organs from cardiac arrest donors are used to address organ shortage, then the supply of donor organs increases, but the risk of primary non-function and graft loss increases due to lack of objective evaluation criteria

Engineering Contradiction:
Improvesupply of donor organsVSAvoidreliability of organ function
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The invention establishes a feedback mechanism by measuring marker substance contents at different time points during perfusion, calculating indicators that reflect organ function status, and using these indicators to determine transplantability. This continuous monitoring and assessment provides reliable feedback on organ viability, enabling safe use of cardiac arrest donor organs while maintaining high transplant success rates.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If objective evaluation criteria are introduced to prevent primary non-function, then the accuracy of transplantability determination improves, but the evaluation process and time required increase

Engineering Contradiction:
Improveobjectivity of transplantability assessmentVSAvoidtime for evaluation process
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention measures marker substance contents at specific key time points during perfusion rather than continuous monitoring, and calculates indicators based on selected critical parameters. This partial measurement approach provides sufficient objective evaluation data to determine transplantability while minimizing the time required for the assessment process.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS20220291225A1Method of evaluating function of organ for transplantation, program for evaluating function of organ for transplantation, and apparatus that evaluates function of organ for transplantation
Publication Date: 2022.09.15 SHIMADZU CORP
  • US20220291225A1 patent drawing
  • US20220291225A1 patent drawing
  • US20220291225A1 patent drawing

AI summary

A method of evaluating a function of an organ for transplantation harvested from a living body, the method includes preparing data representing change over time in content of marker substances in accordance with a perfusion, taking a first tissue sample from the organ for transplantation at first timing in a reperfusion of the organ for transplantation, taking a second tissue sample from the organ for transplantation at second timing after the first timing in the reperfusion, measuring contents of the marker substances in the first tissue sample, measuring contents of the marker substances in the second tissue sample, calculating change in content at the second timing as compared with the first timing for each of the marker substances, and calculating an indicator relating to evaluation of the function of the organ for transplantation using the calculated change in content and the data.